These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1948535)
1. [Causes of death in chronic myeloid leukemia. Analysis of 109 patients]. Cervantes F; Sanz C; Bosch F; Rozman C Sangre (Barc); 1991 Jun; 36(3):183-6. PubMed ID: 1948535 [TBL] [Abstract][Full Text] [Related]
2. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia]. Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774 [TBL] [Abstract][Full Text] [Related]
3. Advances in prognosis of chronic myeloid leukemia. Baccarani M; Russo D; Fanin R; Zuffa E; Tura S Haematologica; 1992; 77(5):377-80. PubMed ID: 1483586 [No Abstract] [Full Text] [Related]
4. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]. Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031 [TBL] [Abstract][Full Text] [Related]
5. [Long-term survival in chronic myeloid leukemia: frequency and fundamental characteristics in a series of 100 patients]. Cervantes F; Bosch F; Terol MJ; Pereira A; Rozman C Sangre (Barc); 1993 Apr; 38(2):93-6. PubMed ID: 8516734 [TBL] [Abstract][Full Text] [Related]
6. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [TBL] [Abstract][Full Text] [Related]
7. Cardiac tamponade in the blastic crisis of chronic myelogenous leukemia. Yamauchi K; Arimori S; Nagao T Tokai J Exp Clin Med; 1992 Jul; 17(2):89-93. PubMed ID: 1440659 [TBL] [Abstract][Full Text] [Related]
8. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121 [TBL] [Abstract][Full Text] [Related]
9. Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Inverardi D; Lazzarino M; Morra E; Bernasconi P; Merante S; Canevari A; Pagnucco G; Bernasconi C Haematologica; 1990; 75(2):146-8. PubMed ID: 2358205 [TBL] [Abstract][Full Text] [Related]
10. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis. Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302 [TBL] [Abstract][Full Text] [Related]
11. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases]. Nese M; de Bellis R; Urtiarte R; Di Landro J Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047 [TBL] [Abstract][Full Text] [Related]
13. Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications. Kantarjian H; O'Brien S; Cortes J; Giles F; Thomas D; Kornblau S; Shan J; Beth Rios M; Keating M; Freireich E; Talpaz M Cancer; 2003 Jul; 98(1):81-5. PubMed ID: 12833459 [TBL] [Abstract][Full Text] [Related]
14. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients]. Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136 [TBL] [Abstract][Full Text] [Related]
15. [Sweet's syndrome associated with accelerated phase (blast crisis) of chronic myeloid leukemia]. Elovaara E; Kariniemi AL; Somer T Duodecim; 1990; 106(8):630-4. PubMed ID: 1670251 [No Abstract] [Full Text] [Related]
16. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395 [TBL] [Abstract][Full Text] [Related]
17. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors. Bishop MR; Henslee-Downey PJ; Anderson JR; Romond EH; Marciniak E; Yankey R; Reeves M; Thompson JS Bone Marrow Transplant; 1996 Oct; 18(4):747-53. PubMed ID: 8899190 [TBL] [Abstract][Full Text] [Related]